Companies were once reliant on developing strong in-house research and development capabilities in order to generate innovation and fill their product pipelines. Increasingly, larger life sciences companies are helping to build their pipelines by looking outside their organisation for opportunities, expertise and solutions. This note looks at how open innovation may be one model by which to achieve this and some of its pitfalls.

This content is restricted to members. To view this content please register or login below to view this content.

Register to receive up-to-date information and advice on tax developments within your industry.